Literature DB >> 500824

Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors.

W B Campbell, C E Gomez-Sanchez, B V Adams, J M Schmitz, H D Itskovitz.   

Abstract

The effect of two prostaglandin synthesis inhibitors, indomethacin and meclofenamate, on angiotensin II (AII)- and III (AIII)-induced aldosterone release was studied in normal and sodium-depleted conscious rats and in adrenal capsular cell suspensions obtained from normal rats. In normal rats, in vivo AII and AIII were equipotent in causing dose-related increases in serum aldosterone concentrations. Indomethacin decreased the basal serum aldosterone levels by 50% and serum renin levels by 43%. In addition, the steroidogenic effects of AII and AIII were reduced by 45 and 63% with 3 mg/kg of indomethacin and 63 and 73% with 10 mg/kg, respectively. In contrast, meclofenamate failed to alter basal serum levels of aldosterone or AII-stimulated aldosterone release but inhibited serum renin levels by 27% and the aldosterone-stimulating effect of AIII by 99%. Indomethacin (3 mg/kg) and meclofenamate (2 mg/kg) inhibited urinary prostaglandin (PG)E(2) and PGF(2alpha) excretion by 63 and 52% and 37 and 31%, respectively. Both inhibitors significantly decreased the adrenal capsular PGE(2) and PGF(2alpha) content and the conversion of [(14)C]arachidonate to [(14)C]PGE(2) and [(14)C]PGF(2alpha). In sodium-depleted rats, indomethacin produced similar effects reducing the control serum aldosterone levels by 29%, AII-stimulated aldosterone by 47%, and completely suppressing the aldosterone response to AIII without altering serum renin activity. In adrenal cell suspensions, similar results were observed with indomethacin inhibiting basal and AII- and AIII-stimulated aldosterone release by 29, 81, and 93%, respectively. Meclofenamate failed to alter basal and AII-stimulated aldosterone release but inhibited that stimulated by AIII by 86%. The present findings suggest that prostaglandins modulate the effects of the renin-angiotensin system by stimulating the release of renin from the kidney and augmenting the steroidogenic effects of AII and AIII in the adrenal cortex.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500824      PMCID: PMC371307          DOI: 10.1172/JCI109615

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Specific receptors for des-Asp1-angiotensin II (("angiotensin III") in rat adrenals.

Authors:  M A Devynck; M G Pernollet; P G Matthews; M C Khosla; F M Bumpus; P Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

2.  Effect of prostaglandin synthetase inhibitors of basal and ACTH-stimulated steroid synthesis by separated adrenocortical zones.

Authors:  A Spät; P Siklós; F A Antoni; K Nagy; K Szirányi
Journal:  J Steroid Biochem       Date:  1977-04       Impact factor: 4.292

3.  Role of prostaglandins in aldosterone production by the human adrenal.

Authors:  K V Honn; W Chavin
Journal:  Biochem Biophys Res Commun       Date:  1976-10-18       Impact factor: 3.575

4.  Phospholipase A and the mechanism of action of aldosterone.

Authors:  T Yorio; P J Bentley
Journal:  Nature       Date:  1978-01-05       Impact factor: 49.962

5.  Effect of prostaglandin synthetase inhibitors on renin and aldosterone in man on a normal or low sodium diet.

Authors:  G Norbiato; M Bevilacqua; U Raggi; P Micossi; C Moroni; A Fasoli
Journal:  Acta Endocrinol (Copenh)       Date:  1978-03

6.  Effect of sodium depletion on the steroidogenic and pressor actions of angiotensin in the rat.

Authors:  W B Campbell; J M Schmitz; H D Itskovitz
Journal:  Clin Sci (Lond)       Date:  1979-04       Impact factor: 6.124

7.  Role of renal prostaglandins in sympathetically mediated renin relase in the rat.

Authors:  W B Campbell; R M Graham; E K Jackson
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

8.  Angiotensin (A I, A II, A III) receptor characterization. Correlation of prostaglandin release with peptide degradation.

Authors:  A L Blumberg; K Nishikawa; S E Denny; G R Marshall; P Needleman
Journal:  Circ Res       Date:  1977-08       Impact factor: 17.367

9.  Demonstration of different contractile mechanisms for angiotensin II and des-Asp1-angiotensin II in rabbit aortic strips.

Authors:  J A Ackerly; A F Moore; M J Peach
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats.

Authors:  W B Campbell; J M Schmitz; H D Itskovitz
Journal:  Endocrinology       Date:  1977-01       Impact factor: 4.736

View more
  9 in total

1.  Specific action of the lipoxygenase pathway in mediating angiotensin II-induced aldosterone synthesis in isolated adrenal glomerulosa cells.

Authors:  J L Nadler; R Natarajan; N Stern
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

2.  Angiotensin alters 45Ca2+ fluxes in bovine adrenal glomerulosa cells.

Authors:  M E Elliott; T L Goodfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

Review 3.  Hyperkalemia in the Hypertensive Patient.

Authors:  Jay Ian Lakkis; Matthew R Weir
Journal:  Curr Cardiol Rep       Date:  2018-03-01       Impact factor: 2.931

Review 4.  Hyperkalemia in patients with heart failure: incidence, prevalence, and management.

Authors:  Akshay S Desai
Journal:  Curr Heart Fail Rep       Date:  2009-12

5.  Angiotensin II relaxations of bovine adrenal cortical arteries: role of angiotensin II metabolites and endothelial nitric oxide.

Authors:  Kathryn M Gauthier; David X Zhang; Lijie Cui; Kasem Nithipatikom; William B Campbell
Journal:  Hypertension       Date:  2008-05-19       Impact factor: 10.190

6.  Differential diagnosis of hyperkalemia: an update to a complex problem.

Authors:  T Eleftheriadis; K Leivaditis; G Antoniadi; V Liakopoulos
Journal:  Hippokratia       Date:  2012-10       Impact factor: 0.471

7.  Effects of NSAIDs on kidney functions and cardiovascular system.

Authors:  Yusuf Ziya Şener; Metin Okşul
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-08       Impact factor: 3.738

Review 8.  Drug-induced impairment of renal function.

Authors:  George Sunny Pazhayattil; Anushree C Shirali
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-12-12

9.  Hyporeninemic hypoaldosteronism in a patient with diabetes mellitus: an unforgettable case report.

Authors:  Naziha Chelaghma; Samson O Oyibo
Journal:  Int Med Case Rep J       Date:  2018-04-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.